Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Update

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 5,800 shares, an increase of 152.2% from the March 31st total of 2,300 shares. Based on an average daily trading volume, of 67,100 shares, the short-interest ratio is currently 0.1 days.

Ocean Biomedical Trading Down 71.1 %

Shares of Ocean Biomedical stock traded down $0.01 on Monday, hitting $0.00. 8,279 shares of the company were exchanged, compared to its average volume of 69,151. Ocean Biomedical has a 1-year low of $0.00 and a 1-year high of $0.18. The company has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.03.

Ocean Biomedical Company Profile

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.